These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

573 related items for PubMed ID: 8939269

  • 1. Rush sublingual immunotherapy in Parietaria allergic patients.
    D'Ambrosio FP, Ricciardi L, Isola S, Savi E, Parmiani S, Puccinelli P, Musarra A.
    Allergol Immunopathol (Madr); 1996; 24(4):146-51. PubMed ID: 8939269
    [Abstract] [Full Text] [Related]

  • 2. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE, Monasterolo G, Coco G, Operti D.
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study.
    Feliziani V, Lattuada G, Parmiani S, Dall'Aglio PP.
    Allergol Immunopathol (Madr); 1995 Oct; 23(5):224-30. PubMed ID: 8526180
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
    Frew AJ, Powell RJ, Corrigan CJ, Durham SR, UK Immunotherapy Study Group.
    J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
    Valovirta E, Jacobsen L, Ljørring C, Koivikko A, Savolainen J.
    Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565
    [Abstract] [Full Text] [Related]

  • 10. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule.
    Colás C, Monzón S, Venturini M, Lezaun A.
    J Allergy Clin Immunol; 2006 Apr; 117(4):810-6. PubMed ID: 16630938
    [Abstract] [Full Text] [Related]

  • 11. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV, Hamelmann E, Zielen S, Kamin W, Bergmann KC, Sieder C, Stenglein S, Seyfried S, Wahn U, DUAL study group.
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis.
    Worm M.
    Eur Ann Allergy Clin Immunol; 2006 Dec; 38(10):355-60. PubMed ID: 17274520
    [Abstract] [Full Text] [Related]

  • 13. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen.
    Skoner D, Gentile D, Bush R, Fasano MB, McLaughlin A, Esch RE.
    J Allergy Clin Immunol; 2010 Mar; 125(3):660-6, 666.e1-666.e4. PubMed ID: 20153030
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S.
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [Abstract] [Full Text] [Related]

  • 18. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
    Crimi N, Li Gotti F, Mangano G, Paolino G, Mastruzzo C, Vancheri C, Lisitano N, Polosa R.
    Ann Ital Med Int; 2004 Apr; 19(2):98-108. PubMed ID: 15317270
    [Abstract] [Full Text] [Related]

  • 19. Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis.
    Didier A, Worm M, Horak F, Sussman G, de Beaumont O, Le Gall M, Melac M, Malling HJ.
    J Allergy Clin Immunol; 2011 Sep; 128(3):559-66. PubMed ID: 21802126
    [Abstract] [Full Text] [Related]

  • 20. Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen.
    Marogna M, Spadolini I, Massolo A, Berra D, Zanon P, Chiodini E, Canonica GW, Passalacqua G.
    Ann Allergy Asthma Immunol; 2009 Jan; 102(1):69-75. PubMed ID: 19205289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.